Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study

Joyce O’Shaughnessy, Susana Gama de Sousa, Josefina Cruz, Lesley J. Fallowfield, Päivi Auvinen, Catarina Pulido and 24 more

Rank
46 of 655
Percentile
top 7.1%
Where
European Journal of Cancer, 2021
Citations
83

From the 2021 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.